Omniox Patents

Patent portfolio assigned to Omniox (verified via public assignee records). Estimated patent count: 4. Preclinical biotech developing H-NOX oxygen-delivery proteins for hypoxia/cancer/stroke (San Carlos, CA). No commercial customers (preclinical). Multiple patents assigned to Omniox Inc. (e.g., US10385116B2 'Polymeric forms of H-NOX proteins', WO2016149562A2 'Modulation of tumor immunity by protein-mediated O2 delivery', plus EP/CN/WO family); count is an estimate of distinct families seen. Wellcome Trust award is a grant, not a customer.